台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.50%
  • 成交量
    25
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-統一-桃園 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

統一-桃園 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/06/1200.002100.50101.00-2155-1.29%
2024/06/0600.003102.50102.50-3157-1.90%
2024/05/2400.000102.50103.000157-0.02%
2024/05/165107.0000.00107.0051503.33%
2024/05/14196.87698.50102.00-5144-3.44%
2024/05/132107.0000.00107.0021271.57%
2024/04/161113.5000.00114.0011110.90%
2024/04/151116.0000.00117.0011070.93%
2024/04/122117.5000.00118.0021041.91%
2024/04/1000.001126.50127.00-195-1.04%
2024/03/280124.0000.00122.500670.00%
2024/03/270124.0000.00122.000660.03%
2024/03/2000.001122.00121.50-156-1.77%
2024/03/191122.0000.00123.001551.81%
2024/03/151120.504120.50121.50-347-6.37%
2024/03/1400.002119.00119.00-243-4.62%
2024/03/1200.002116.00117.00-238-5.15%
2024/03/1100.001115.00114.50-136-2.77%
2024/02/2600.001112.00112.00-132-3.09%
2024/02/152111.0000.00112.002316.39%
2024/02/021112.0000.00112.001313.16%
2024/01/221111.0000.00111.501293.34%
2024/01/101111.5000.00111.001283.46%
2024/01/093112.6700.00112.5032710.79%
2024/01/081114.0000.00114.001253.87%
2023/04/101120.5000.00120.501392.56%
2023/03/2300.005115.40115.00-529-16.69%
2023/03/224116.0000.00115.5042913.53%
2023/03/1300.001111.50111.00-134-2.90%
2022/12/0800.004102.75105.00-438-10.40%
2022/12/072100.251102.50100.501362.72%
2022/12/062102.502105.00102.000340.00%
2022/12/0500.001104.00101.50-132-3.07%
2022/11/301100.0000.00100.001273.57%
2022/11/081101.001102.50101.000190.00%
2022/11/04299.3000.0099.2021910.48%
2022/11/0300.002100.50101.00-219-10.48%
2022/10/31199.5000.0099.201175.66%
2022/10/2800.001101.50100.00-116-5.91%
2022/10/182101.7500.00101.5021413.39%
2022/10/1200.001104.50104.50-116-6.12%
2022/10/1100.001103.50104.00-116-6.17%
2022/10/031103.5000.00103.501166.03%
2022/09/2600.001105.50105.00-116-6.06%
2022/09/202106.5000.00107.5021612.15%
2022/09/1600.001108.00108.00-116-5.94%
2022/09/121107.0000.00107.501175.70%
2022/08/301110.0000.00110.501195.24%
2022/08/251111.5000.00111.501204.92%
2022/08/241112.001113.00111.500200.00%
2022/08/231110.001111.00111.500210.00%
2022/08/171112.0000.00112.501224.46%
2022/08/1100.001113.50113.00-124-4.02%
2022/08/1000.002111.25112.00-226-7.59%
2022/08/081110.0000.00111.001352.83%
2022/07/271111.0000.00111.001442.24%
2022/07/261111.001112.00112.000440.00%
2022/07/221111.001112.50112.500440.00%
2022/07/2100.001113.00112.00-144-2.26%
2022/07/1900.001109.00109.50-143-2.30%
2022/07/1800.001106.50107.00-142-2.37%
2022/06/29297.8000.0097.702454.37%
2022/06/10199.6000.00100.001462.16%
2022/06/0900.001102.00100.00-145-2.18%
2022/06/0800.002100.25100.50-245-4.44%
2022/05/3100.004100.50101.00-444-8.98%
2022/05/16699.6700.0098.7064114.49%
2022/05/13299.904101.50102.50-240-5.00%
2022/05/122109.0000.00109.002335.96%
2022/05/102120.5000.00121.502257.96%
2022/05/041121.002123.00123.50-125-3.92%
2022/05/0300.001122.00122.50-125-3.87%
2022/04/261122.5000.00122.001253.90%
2022/04/2200.001124.00124.00-125-3.88%
2022/04/211124.5000.00124.001253.87%
2022/04/1500.001125.00124.50-125-3.88%
2022/04/1400.001124.50126.00-125-3.95%
2022/04/132133.7500.00134.002248.16%
2022/03/2100.001132.00132.00-119-5.20%
2022/03/1000.001125.50126.00-122-4.48%
2022/02/251124.0000.00124.501224.50%
2022/01/041125.0000.00126.501293.42%
2021/12/151125.0000.00123.501323.04%
2021/09/0800.000.1143.50141.00-0.134-0.14%
2021/08/0400.001140.50144.00-136-2.72%
2021/08/031156.0000.00156.001352.80%
2020/06/1600.002113.00112.50-252-3.79%
2020/06/152111.5000.00111.502533.72%
2020/02/0700.001101.00101.00-127-3.67%
2019/04/1800.001110.00109.00-137-2.64%
2019/03/291108.5000.00108.501323.11%
2018/05/0725133.0025131.90131.5001240.00%
2018/03/191128.501127.50127.5001760.00%
2018/03/021120.001121.00120.0001750.00%
2018/01/191125.501127.00124.0001480.00%
2018/01/172120.502120.50121.5001290.00%
2018/01/1600.001116.50116.00-1118-0.84%
2018/01/152117.001116.00118.0011140.87%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音